TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide outbreak, known as coronavirus disease 2019 (COVID-19). Alongside vaccines, antiviral therapeutics is an important part of the healthcare response to COVID-19. We previously reported that TEMPOL, a small molecule sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Maio, Nunziata, Cherry, Sara, Schultz, David C., Hurst, Brett L., Linehan, W. Marston, Rouault, Tracey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444323/
https://www.ncbi.nlm.nih.gov/pubmed/36093377
http://dx.doi.org/10.1016/j.isci.2022.105074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444323/
https://www.ncbi.nlm.nih.gov/pubmed/36093377
http://dx.doi.org/10.1016/j.isci.2022.105074

Ejemplares similares